Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Intranasal GSK1004723 in Seasonal Allergic Rhinitis
NCT00824356Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK-1004723 in seasonal allergic rhinitis (SAR) (3 arms), sponsored by GSK. Primary endpoint: Total Nasal Symptom Score. Started Jun 2008; status: completed.
02
Drugs
GSK-1004723
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00824356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824356.